GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
114 hedge funds and large institutions have $184M invested in G1 Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 45 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+7
Holders Change %
+6.54%
% of All Funds
1.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
27
Reduced
45
Closed
11
Calls
$1.24M
Puts
$636K
Net Calls
+$603K
Net Calls Change
+$663K
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$3.71M |
| 2 |
CA
2
CHI Advisors
New York
|
$3.71M |
| 3 |
HF
3
HRT Financial
New York
|
$1.55M |
| 4 |
PCM
4
Pinz Capital Management
New York
|
$1.42M |
| 5 |
RJA
5
Raymond James & Associates
St Petersburg,
Florida
|
$3.02M |
